Last --
Change Today 0.00 / 0.00%
Volume 0.0
PFZ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
SIX Swiss Ex
Stockholm
London
Sao Paulo
Bogota
All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for pfizer inc (PFZ)

Although debt as a percent of total capital increased at Pfizer Inc. over the last fiscal year to 32.44%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, there are enough liquid assets to satisfy current obligations. Accounts Receivable are typical for the industry, with 70.87 days worth of sales outstanding. Last, Pfizer Inc. is among the most efficient in its industry at managing inventories, with only 241.82 days of its Cost of Goods Sold tied up in inventory.
Currency in
Millions of US Dollars
As of:Dec 31
2010
Restated
Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
4 Year
Trend
Assets    
Cash and Equivalents1,735.03,182.010,081.02,183.0
Short-Term Investments26,277.023,270.022,318.030,225.0
Trading Asset Securities--8.0--90.0
TOTAL CASH AND SHORT TERM INVESTMENTS28,012.026,460.032,399.032,498.0
Accounts Receivable13,380.013,058.010,675.09,357.0
Notes Receivable467.0------
Other Receivables5,925.05,023.02,670.03,036.0
TOTAL RECEIVABLES19,772.018,081.013,345.012,393.0
Inventory8,275.06,610.06,076.06,166.0
Deferred Tax Assets, Current3,000.04,000.03,500.02,100.0
Other Current Assets1,954.05,666.09,511.03,087.0
TOTAL CURRENT ASSETS61,013.060,817.064,831.056,244.0
Gross Property Plant and Equipment31,377.029,237.025,965.025,678.0
Accumulated Depreciation-12,732.0-13,316.0-12,752.0-13,281.0
NET PROPERTY PLANT AND EQUIPMENT18,645.015,921.013,213.012,397.0
Goodwill43,928.044,569.043,661.042,519.0
Long-Term Investments10,051.010,814.015,149.016,784.0
Loans Receivable, Long Term299.0------
Deferred Tax Assets, Long Term1,200.01,200.0611.0569.0
Other Intangibles57,555.051,184.045,146.039,385.0
Other Long-Term Assets2,323.03,497.03,187.04,203.0
TOTAL ASSETS195,014.0188,002.0185,798.0172,101.0
    
LIABILITIES & EQUITY    
Accounts Payable3,994.03,678.02,921.03,234.0
Accrued Expenses2,410.02,120.01,875.01,792.0
Short-Term Borrowings2,101.04,010.03,975.03,967.0
Current Portion of Long-Term Debt/Capital Lease3,505.06.02,449.02,060.0
Current Income Taxes Payable951.01,009.0979.0678.0
Other Current Liabilities, Total15,567.017,736.016,987.011,583.0
TOTAL CURRENT LIABILITIES28,636.028,909.029,186.023,366.0
Long-Term Debt38,411.034,940.031,069.030,763.0
Minority Interest452.0431.0418.0313.0
Pension & Other Post-Retirement Benefits9,229.09,699.011,273.07,303.0
Deferred Tax Liability Non-Current18,628.018,861.021,193.025,590.0
Other Non-Current Liabilities11,845.012,972.011,399.08,459.0
TOTAL LIABILITIES106,749.0105,381.0104,120.095,481.0
Preferred Stock Convertible52.045.039.033.0
TOTAL PREFERRED EQUITY52.045.039.033.0
Common Stock444.0445.0448.0453.0
Additional Paid in Capital70,760.071,423.072,608.077,283.0
Retained Earnings42,716.046,210.054,240.069,732.0
Treasury Stock-22,712.0-31,801.0-40,122.0-67,923.0
Comprehensive Income and Other-3,447.0-4,132.0-5,953.0-3,271.0
TOTAL COMMON EQUITY87,761.082,145.081,221.076,274.0
TOTAL EQUITY88,265.082,621.081,678.076,620.0
TOTAL LIABILITIES AND EQUITY195,014.0188,002.0185,798.0172,101.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFZ:LN $0.00 USD 0.00

PFZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €111.01 EUR -1.82
Gilead Sciences Inc $105.39 USD -0.08
Merck & Co Inc $60.28 USD -0.30
Novartis AG SFr.87.75 CHF -0.50
Roche Holding AG SFr.282.20 CHF -1.00
View Industry Companies
 

Industry Analysis

PFZ

Industry Average

Valuation PFZ Industry Range
Price/Earnings 19.0x
Price/Sales 3.8x
Price/Book 2.5x
Price/Cash Flow 13.0x
TEV/Sales 2.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.